August 3, 2023
August 3, 2023
Categories

Dr. Barbara Burtness, Head and Neck Cancer Committee Chair, on a new way to classify HPV-associated head and neck cancers

Do you like it?
Read more
August 3, 2023
August 3, 2023
Categories

AACR’s Clinical Cancer Research publishes a review article, “The New NCI Precision Medicine Trials”

Do you like it?
Read more
August 3, 2023
August 3, 2023
Categories

Researchers identify two new subtypes of HPV-associated head and neck cancers

Do you like it?
Read more
July 31, 2023
July 31, 2023
Categories

Proceedings of the National Academy of Sciences publishes the discovery of two new subtypes of HPV-associated head and neck cancers

Do you like it?
Read more
June 16, 2023
June 16, 2023
Categories

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

Do you like it?
Read more
June 1, 2023
June 1, 2023
Categories

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

Do you like it?
Read more
May 30, 2023
May 30, 2023
Categories

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

Do you like it?
Read more
April 21, 2023
April 21, 2023
Categories

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

Do you like it?
Read more
June 22, 2022
June 22, 2022
Categories

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group